Related Experiment Video
Updated: Jun 5, 2026
09:30
Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 8, 2010
Matrix metalloproteinases in myasthenia gravis
Geir Helgeland1, Axel Petzold, Steven Paul Luckman
1Department of Clinical Medicine, University of Bergen, Bergen, Norway. geir.helgeland@gmail.com
European Neurology
|January 8, 2011
Summary
Elevated matrix metalloproteinase (MMP) levels, including MMP2 and MMP9, are present in myasthenia gravis (MG) patients, independent of acetylcholine receptor antibodies. This suggests MMPs contribute to MG pathogenesis and ocular MG (OMG) may be systemic.
Area of Science:
- Immunology
- Biochemistry
- Neurology
Background:
- Myasthenia gravis (MG) is an autoimmune neuromuscular junction disorder characterized by muscle weakness.
- Ocular MG (OMG) presents with isolated periocular symptoms.
- Matrix metalloproteinases (MMPs) are implicated in autoimmune pathogenesis and tissue degradation.
Purpose of the Study:
- To investigate serum levels of MMP2, MMP3, and MMP9 in patients with myasthenia gravis.
- To explore the relationship between MMP levels and disease subtypes (generalized MG vs. ocular MG) and anti-acetylcholine receptor (AChR) antibody status.
Main Methods:
- Serum samples from MG patients and controls were analyzed.
- Enzyme-linked immunosorbent assay (ELISA) was used to quantify total levels of MMP2, MMP3, and MMP9.
Main Results:
- MG patients exhibited significantly higher serum concentrations of MMP2 and MMP9 compared to healthy controls.
- A subset of MG patients showed elevated MMP3 levels.
- MMP levels did not differ significantly between generalized MG and ocular MG subgroups.
- The observed increases in MMP levels were independent of the presence of anti-AChR antibodies.
Conclusions:
- Elevated serum MMP2, MMP3, and MMP9 levels suggest a role for these enzymes in the pathogenesis of myasthenia gravis.
- The findings indicate that MMPs may contribute to MG development irrespective of AChR antibody status.
- Similar MMP profiles in generalized MG and ocular MG support the classification of ocular MG as a systemic manifestation.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:23Role of Matrix Metalloproteases in Degradation of ECM
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
A...